FHTX: Foghorn Therapeutics Inc. Common Stock Company Profile & Statistics

Foghorn Therapeutics Inc. Common Stock Profile

About

Foghorn Therapeutics Inc. engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system. Foghorn Therapeutics Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Adrian Gottschalk

Headquarters

99 Coolidge Avenue, Suite 500
Watertown, MA 02472, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

106

Foghorn Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

287.69M

Enterprise Value

205.56M

Enterprise Value/EBITDA(ttm)

-2.42

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

9.12

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-240.33%

Profit Margin(ttm)

-245.61%

Return on Equity(ttm)

Return on Invested Capital(ttm)

91.59%

Return on Assets(ttm)

-33.46%

Income Statement

Revenue(ttm)

30.91M

Revenue Per Share(ttm)

0.53

Gross Profit(ttm)

30.91M

EBITDA(ttm)³

-84.98M

Net Income Available to Common(ttm)

-74.28M

Diluted EPS(ttm)

-1.17

Share Statistics

Beta (5Y Monthly)

3.02

52-Week Change

28.35%

S&P 500 52-Week Change

13.77%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

58.70M

Dividend Yield

0.00%

Float⁴

54.25M

% Held by Insiders

7.58%

% Held by Institutions

61.55%

Balance Sheet

Total Cash(mrq)

160.14M

Total Cash Per Share(mrq)

2.73

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.73%

Quick Ratio(mrq)

2.73%

Book Value Per Share(mrq)

-1.92

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.37

Free Cash Flow(ytd)

-86.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

FHTX

Foghorn Therapeutics Inc. Common Stock